Chapter 432 Rheumatic Heart Disease
Rheumatic involvement of the valves and endocardium is the most important manifestation of rheumatic fever (Chapter 176). The valvular lesions begin as small verrucae composed of fibrin and blood cells along the borders of one or more of the heart valves. The mitral valve is affected most often, followed in frequency by the aortic valve; right-sided heart manifestations are rare. As the inflammation subsides, the verrucae tend to disappear and leave scar tissue. With repeated attacks of rheumatic fever, new verrucae form near the previous ones, and the mural endocardium and chordae tendineae become involved.
Patterns of Valvular Disease
Mitral Insufficiency
Treatment
In patients with mild mitral insufficiency, prophylaxis against recurrences of rheumatic fever is all that is required. Treatment of complicating heart failure (Chapter 436), arrhythmias (Chapter 429), and infective endocarditis (Chapter 431) is described elsewhere. Afterload-reducing agents (ACE inhibitors or angiotensin receptor blockers) may reduce the regurgitant volume and preserve left ventricular function. Surgical treatment is indicated for patients who despite adequate medical therapy have persistent heart failure, dyspnea with moderate activity, and progressive cardiomegaly, often with pulmonary hypertension. Although annuloplasty provides good results in some children and adolescents, valve replacement may be required. In patients with a prosthetic mitral valve replacement, prophylaxis against bacterial endocarditis is warranted for dental procedures, as the routine antibiotics taken by these patients for rheumatic fever prophylaxis are insufficient to prevent endocarditis.
Camara EJ, Neubauer C, Camara GF, et al. Mechanisms of mitral valvar insufficiency in children and adolescents with severe rheumatic heart disease: an echocardiographic study with clinical and epidemiological correlations. Cardiol Young. 2004;14:527-532.
Cilliers AM. Rheumatic fever and its management. BMJ. 2006;333:1153-1156.
Fesslova V, Bardare M. Rheumatic fever in the 21st century. Cardiol Young. 2004;14:465. author reply 465–466
Figueroa FE, Fernandez MS, Valdes P, et al. Prospective comparison of clinical and echocardiographic diagnosis of rheumatic carditis: long term follow up of patients with subclinical disease. Heart. 2001;85:407-410.
Guilherme L, Ramasawmy R, Kalil J. Rheumatic fever and rheumatic heart disease: genetics and pathogenesis. Scand J Immunol. 2007;66:199-207.
Marijon E, Ou P, Celermajer DS, et al. Prevalence of rheumatic heart disease detected by echocardiographic screening. N Engl J Med. 2007;357:470-476.
Narula J, Chandrasekhar Y, Rahimtoola S. Diagnosis of active rheumatic carditis. Circulation. 1999;100:1576-1581.
Stollerman GH. Rheumatic fever in the 21st century. Clin Infect Dis. 2001;33:806-814.